Ingrid E. Scheffer

50 Flemington Rd
Parkville, VIC 3052, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 521 publications

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

Journal: Epilepsia open

Published: June 08, 2026

Viewpoint: Decline in Speech and Language Skills May Signal Childhood Dementia.

Viewpoint: Decline in Speech and Language Skills May Signal Childhood Dementia.

Journal: American journal of speech-language pathology

Published: May 29, 2026

Genome sequencing boosts diagnostic yield for the developmental and epileptic encephalopathies.

Genome sequencing boosts diagnostic yield for the developmental and epileptic encephalopathies.

Journal: medRxiv : the preprint server for health sciences

Published: May 07, 2026

Precision Antisense Oligonucleotide Therapy Amenability for Infantile Genetic Epilepsies.

Precision Antisense Oligonucleotide Therapy Amenability for Infantile Genetic Epilepsies.

Journal: JAMA neurology

Published: May 04, 2026

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

Journal: Epilepsia open

Published: April 01, 2026

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

Journal: Epilepsia

Published: March 13, 2026

On-site exposure to clinical epilepsy practice for experimental scientists engaged in epilepsy research: A pilot study by the ILAE commission on neurobiology.

On-site exposure to clinical epilepsy practice for experimental scientists engaged in epilepsy research: A pilot study by the ILAE commission on neurobiology.

Journal: Epilepsia open

Published: March 06, 2026

Correlation of polygenic risk score and clinical phenotype in patients with genetic generalized epilepsy.

Correlation of polygenic risk score and clinical phenotype in patients with genetic generalized epilepsy.

Journal: Epilepsia

Published: February 25, 2026

Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy.

Diagnostic Yield of Comprehensive Reanalysis After Nondiagnostic Short-Read Genome Sequencing in Infants With Unexplained Epilepsy.

Journal: Neurology

Published: February 13, 2026

Activating Ras-MAPK pathway variants drive hippocampal clonal competition in human epilepsy.

Activating Ras-MAPK pathway variants drive hippocampal clonal competition in human epilepsy.

Journal: bioRxiv : the preprint server for biology

Published: February 09, 2026

Activating Ras-MAPK pathway variants drive hippocampal clonal competition in human epilepsy.

Activating Ras-MAPK pathway variants drive hippocampal clonal competition in human epilepsy.

Journal: bioRxiv : the preprint server for biology

Published: February 09, 2026

Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity.

Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity.

Journal: Neurology

Published: January 14, 2026

Showing 1-12 of 521

Last Updated: 09/26/2026